Rasio Nilai Pasar marang Nilai Buku: Gritstone bio (GRTS)

GRTS (Gritstone bio Inc.) - tandha merek perusahaan

The prospects for Gritstone bio, Inc. (GRTS) depend on the pace of personalized drug releases and data regarding solid tumors. This chart of the market cap to book value ratio demonstrates valuation dynamics, where the indicator stands at 0.16. The innovative platform creates a foundation for future payments from pharma behemoths, while a strong staff of bioinformaticians and immunologists, attracted by stock options, guarantees the success of clinical trials.

Rasio Kapitalisasi marang Nilai Buku gritstonebio.com (GRTS): kanggo periode 04.07.2022 - 02.11.2024
Produk asil prodhuksi gritstonebio.com

For Gritstone bio, Inc. (GRTS), the chart of the market capitalization to net asset ratio reflects a critical discrepancy between the exchange price and the actual value of resources. This metric is calculated by dividing the market capitalization by the value of equity, which allows for the determination of the degree of asset overvaluation or the level of discount. Amid bankruptcy and a shrinking R&D pipeline, this indicator reveals the speculative nature of the quotes. It is essential for investors to correlate this data with the risks of underfunding anti-cancer developments.

Analisis perusahaan pesaing

ImmunityBio, Inc. (IBRX) - Rasio Nilai Pasar marang Nilai Buku|IMCR - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Janux Therapeutics, Inc.|Koefisien Nilai Pasar marang Nilai Buku Arcus Biosciences Inc RCUS|Rasio Nilai Pasar marang Nilai Buku Zymeworks Corp (ZYME)|Tango Therapeutics Corp - Rasio Kapitalisasi marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku IOVA (Iovance Biotherapeutics)|IMTX - Rasio Kapitalisasi marang Aset Bersih|XNCR - Rasio Nilai Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku Compass Therapeutics Inc|Replimune Corp (REPL) - Rasio Nilai Pasar marang Nilai Buku|LYEL (Lyell Pharma) - Rasio Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Innate Pharma S.A.|Koefisien Nilai Pasar marang Nilai Buku Pyxis PYXS|Rasio Kapitalisasi Pasar marang Nilai Buku CGEN|IO Biotech Inc (IOBT) - Rasio Nilai Pasar marang Ekuitas|Sutro Bio - Rasio Kapitalisasi marang Aset Bersih|MiNK Therapeutics, Inc (INKT) - Koefisien Nilai Pasar marang Nilai Buku|HOWL: Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku IMMX (Immix Biopharma, Inc.)|ALXO: Rasio Kapitalisasi Pasar marang Nilai Buku|CUE - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku PDS Biotech|Rasio Kapitalisasi marang Aset Bersih Sonnet BioTherapeutics Holdings Inc. (SONN)|Rasio Nilai Pasar marang Nilai Buku MAIA Biotechnology (MAIA)|Rasio Kapitalisasi marang Aset Bersih liminatuspharma.com LIMN|LAVA Therapeutics - Rasio Kapitalisasi marang Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku NextCure Inc NXTC|LPTX - Rasio Nilai Pasar marang Nilai Buku|INTS (Intensity Therapeutics) - Rasio Kapitalisasi marang Nilai Buku|senseibio.com (SNSE) - Rasio Nilai Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku therivabio.com (TOVX)|Rasio Kapitalisasi marang Aset Bersih KA|NEXI - Rasio Nilai Pasar marang Ekuitas|Rasio Kapitalisasi marang Aset Bersih TSBX (Turnstone Biologics)|Multiplikator Kapitalisasi Pasar marang Nilai Buku VCNX|Rasio Kapitalisasi Pasar marang Nilai Buku HARP (Harpoon Therapeutics)